Figure 4 | Scientific Reports

Figure 4

From: Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

Figure 4

Blood glucose levels (1), plasma inflammatory profile and Linear Regression analyses (2), and plasma lipid profile (3). LFD: low-fat diet, HFD: high-fat diet, M: metformin, PB-L: low dose probucol, PB-H: high dose probucol, PBUDCA: probucol-ursodeoxycholic acid microcapsules, and UDCA: ursodeoxycholic acid microcapsules. Data are mean ± SEM. *p < 0.05 and **p < 0.01 compared with HFD.

Back to article page